Type 2 Diabetes Key Messages
 Click to view key message slide set Metformin should be used as a first-line medication in almost every patient with type 2 diabetes. |
 Click to view key message slide set DPP-4 inhibitors and GLP-1 agonists should not be used first line in patients with type 2 diabetes because metformin, sulfonylureas and insulin are more efficacious. |
 Click to view key message slide set HbA1C goals should be individualized for each patient with type 2 diabetes: less than 7% for most patients and less than 8% for specific high-risk subgroups. Patients with type 2 diabetes should have an HbA1C test every three to six months. |
|